thumbnail
Deal MakingGenmab bolsters ADC portfolio through $1.8bn ProfoundBio buyGenmab bolsters ADC portfolio through $1.8bn ProfoundBio buy
Genmab will acquire antibody-drug conjugate (ADC) platform developer ProfoundBio in an all-cash transaction.